Financial Statements — CGON
Balance Sheet
(in billions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 0.03 | 0.05 | 0.01 | 0.04 | 0.04 | 0.03 | 0.08 |
| Short-term Investments | 1.04 | 0.64 | 0.65 | 0.65 | 0.50 | 0.53 | 0.49 |
| Accounts Receivable | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Inventory | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Total Current Assets | 1.10 | 0.70 | 0.67 | 0.70 | 0.55 | 0.56 | 0.58 |
| Property, Plant & Equipment | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.01 | 0.01 | -- | -- | -- | -- | -- |
| Intangible Assets | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 |
| Total Assets | 1.14 | 0.73 | 0.70 | 0.73 | 0.55 | 0.56 | 0.58 |
| Accounts Payable | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Long-term Debt | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Total Non-current Liabilities* | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Retained Earnings | (0.44) | (0.34) | (0.29) | (0.25) | (0.19) | (0.17) | (0.15) |
| Total Stockholder Equity | 1.09 | 0.69 | 0.67 | 0.70 | 0.54 | 0.55 | 0.57 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Total Revenue | 1.08 | 2.32 | 1.67 | 0.00 | 0.05 | 0.46 | 0.04 | 0.11 | 0.53 |
| Research & Development | 43.73 | 29.96 | 27.88 | 31.33 | 27.47 | 26.80 | 19.62 | 18.47 | 17.21 |
| Selling, General & Admin | 20.78 | 17.99 | 23.33 | 17.41 | 14.79 | 11.71 | 8.72 | 7.49 | 5.79 |
| Total Operating Expenses | -- | -- | -- | 48.74 | 42.26 | 38.51 | 28.34 | 25.96 | 23.00 |
| Operating Income | (66.39) | (48.70) | (51.13) | (48.74) | (42.20) | (38.05) | (28.29) | (25.85) | (22.47) |
| Net Income | (60.20) | (41.31) | (43.81) | (41.43) | (34.45) | (31.80) | (20.40) | (18.90) | (16.93) |
| Basic EPS | (0.71) | (0.52) | (0.57) | (0.54) | (0.45) | (0.47) | (0.30) | (0.28) | (0.36) |
| Diluted EPS | (0.71) | (0.52) | (0.57) | (0.54) | (0.45) | (0.47) | (0.30) | (0.28) | (0.36) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | (56.94) | (36.22) | (38.89) | (27.96) | (29.28) | (20.66) | (15.92) | (16.12) | (26.01) |
| Capital Expenditures | 0.30 | 0.01 | 0.10 | 0.01 | 0.02 | 0.21 | -0.00 | 0.01 | 0.01 |
| Free Cash Flow* | (57.25) | (36.22) | (38.99) | (27.97) | (29.29) | (20.87) | (15.92) | (16.13) | (26.02) |
| Investing Cash Flow | (334.84) | (75.50) | 15.05 | 1.41 | (186.77) | 10.91 | (161.39) | 103.36 | (307.44) |
| Financing Cash Flow | 393.00 | 99.07 | 54.37 | (0.30) | 0.45 | 223.41 | 2.17 | 0.04 | 402.66 |
* Derived from reported values
